smoldering multiple myeloma

Showing 26 - 37 of 37

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma, Myeloma, Smoldering Multiple Myeloma Trial run by the NCI ((Anti-KIR))

Terminated
  • Multiple Myeloma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 7, 2019

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Reykjavík (Carfilzomib, Lenalidomide, Dexamethasone)

Enrolling by invitation
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Reykjavík, Iceland
    Landspitali University Hospital
Aug 14, 2019

Smoldering Multiple Myeloma Trial in United States (Elotuzumab (BMS-901608; HuLuc63))

Completed
  • Smoldering Multiple Myeloma
  • Elotuzumab (BMS-901608; HuLuc63)
  • San Diego, California
  • +11 more
Dec 21, 2017

Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance Trial run by the NCI (18-NaF

Completed
  • Multiple Myeloma
  • +2 more
  • 18-NaF PET
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 7, 2017

Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma Trial in Boston (Relaxation Response Resiliency

Completed
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Multiple Myeloma
  • Relaxation Response Resiliency Program (3RP)
  • Boston, Massachusetts
  • +2 more
Mar 15, 2017

Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Smoldering Multiple Myeloma Trial in Cleveland (celecoxib,

Completed
  • Monoclonal Gammopathy of Undetermined Significance
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Foundation
Dec 28, 2016

Smoldering Multiple Myeloma Trial in United States (PVX-410)

Completed
  • Smoldering Multiple Myeloma
  • PVX-410
  • Atlanta, Georgia
  • +5 more
Sep 26, 2016

Smoldering Multiple Myeloma Trial in Lund (BI-505)

Terminated
  • Smoldering Multiple Myeloma
  • Lund, Sweden
    Department of Hemtaology, Skåne University Hospital
May 25, 2015

Smoldering Multiple Myeloma Trial (Simvastatin)

Withdrawn
  • Smoldering Multiple Myeloma
  • (no location specified)
Apr 15, 2015

Smoldering Multiple Myeloma Trial in United States (IPH2101)

Completed
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
  • +4 more
Apr 11, 2014

Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in

Terminated
  • Monoclonal Gammopathy of Undetermined Significance
  • +2 more
  • Omega 3 Fatty Acid
  • Huntington, West Virginia
    Edwards Comprehensive Cancer Center
Nov 18, 2013